Abstract
This paper reviews the aetiology, prevalence and treatment of gynaecomastia. Gynaecomastia is a proliferation of male breast tissue apparently caused by alterations in the ratio of oestrogen:androgen levels. It is common in the general population, resulting from normal physiological changes and various pathological causes. Gynaecomastia is also induced by many drug treatments, including hormonal therapies for prostate cancer. Prophylactic radiotherapy appears to be effective against gynaecomastia in this population. Surgery is an option for intractable cases, and some medical treatments have been reported, although there is a paucity of data evaluating such therapies.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 4 print issues and online access
$259.00 per year
only $64.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tyrrell, C. Gynaecomastia: aetiology and treatment options. Prostate Cancer Prostatic Dis 2, 167–171 (1999). https://doi.org/10.1038/sj.pcan.4500314
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.pcan.4500314
Keywords
This article is cited by
-
Profylactische tepelbestraling bij bicalutamidegebruik vanwege prostaatkanker: klinische noodzaak?
Tijdschrift voor Urologie (2014)
-
Gynecomastia in patients with prostate cancer: update on treatment options
Prostate Cancer and Prostatic Diseases (2006)